Navigation Links
Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
Date:5/31/2008

(20%) of patients experienced at least 1 episode of >/= Grade 4 toxicity, most commonly thrombocytopenia (5%) and neutropenia (3%). A total of 50% of patients experienced serious adverse events (SAEs) during the studies. The most commonly reported SAEs included pneumonia (7%), pyrexia (6%), diarrhea (5%), vomiting (4%), and nausea, dehydration, dyspnea and thrombocytopenia (each 3%). Adverse events thought by the investigator to be drug-related and leading to discontinuation occurred in 22% of patients. The reasons for discontinuation included peripheral neuropathy (8%), asthenic conditions (3%) and thrombocytopenia and diarrhea (each 2%). In total, 2% of the patients died and the cause of death was considered by the investigator to be possibly related to study drug: including reports of cardiac arrest, congestive heart failure, respiratory failure, renal failure, pneumonia and sepsis.

For more information about VELCADE clinical trials, patients and physicians can contact the Millennium Medical Product Information Department at 1-866-VELCADE (1-866-835-2233).

About Millennium

Millennium Pharmaceuticals, The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical development pipeline of product candidates. Millennium research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. Additional information about Millennium is available through its website, http://www.millennium.com.

This press release contains "forward-looking statements," including statements about the Company's growth and development of products. Various important r
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)...  Based on its recent analysis of the breast imaging ... 2014 North American Frost & Sullivan Award for Technology Innovation ... imaging solutions for the early detection of breast cancer. Over ... new solutions and has expanded its global reach to cover ... , Asia and ...
(Date:8/26/2014)... Holdings, Inc. (NYSE and SIX: ZMH), a global leader in ... approved the payment of a quarterly cash dividend to stockholders ... cash dividend of $0.22 per share will be paid on ... of the close of business on September 26, 2014.  Future ... of Directors and may be adjusted as business needs or ...
(Date:8/25/2014)... 25, 2014  In collaboration with Airlink and ... Direct Relief today loaded a charter jet with emergency ... the Ebola epidemic in Liberia . ... requested gloves, masks, gowns, and other medical resources, follows ... "Flights going into the country are becoming rarer ...
Breaking Medicine Technology:Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5Ebola Outbreak: Six Nonprofits Team Up to Fill a 737 with 15,000 Pounds of Medical Supplies 2
... Inc. today announced that it has been awarded a ... $600,000 from the National Institute of Allergy and Infectious ...  The grant will be used to demonstrate the feasibility ... platelet recovery and improve survival in a mouse model ...
... TOPEX, Inc. announces the sale of its skin cancer ... energy SRT 100 superficial radiotherapy treatment system. Since TOPEX ... operating worldwide at hospital radiation oncology centers, dermatology and ... The low energy superficial radiotherapy system provides patients an ...
Cached Medicine Technology:Bolder BioTechnology Announces $600,000 Grant from NIH to Study Long-Acting IL-11 Analog in Treating Acute Radiation Syndrome 2TOPEX Sells Skin Cancer Business Operations to SENSUS Healthcare 2
(Date:8/27/2014)... August 27, 2014 ALS Insights is ... optimism and comfort. It features a series of compelling ... ALS. They share their insights, in searing honesty, about ... the impact on children, what happened in the final ... Bucket Challenge has created a dramatic increase in public ...
(Date:8/27/2014)... 2014 Inspira Marketing Group ... to go the distance this September by logging their ... Run. Walk. Ride. initiative, hosted by Alex’s Lemonade Stand ... childhood cancer. September represents National Childhood Cancer Awareness ... Inspira Marketing Group has teamed up with event founder ...
(Date:8/27/2014)... A recently published study ... time in correcting coagulopathy to prevent permanent injury or ... anticoagulants and examines medical conditions alleged to be caused ... anticoagulants have been approved by the FDA to reduce ... also known to affect the consistency of the anticoagulation ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 In My Solitude, ... Candle Collection” to provide a growing number of women from ... tool for goal setting and relaxing at the same time. ... candles, uses scent memory and visualization to help women stay ... life each time they light a candle and enjoy the ...
(Date:8/27/2014)... North Carolina (PRWEB) August 27, 2014 ... did so by necessity when no-one would join her on ... try canyoneering – an extreme sport involving ropes, harnesses and ... my first experience with solo travel but definitely not my ... years, having adventures that pushed me to the edge, and ...
Breaking Medicine News(10 mins):Health News:ALS Insights Launched as Web Resource of Interviews and Information 2Health News:Alex’s Lemonade Stand Foundation Kicks Off Alex’s Million Mile – Run. Walk. Ride. with Labor Day 5k Run in New York City’s Hudson River Park 2Health News:Alex’s Lemonade Stand Foundation Kicks Off Alex’s Million Mile – Run. Walk. Ride. with Labor Day 5k Run in New York City’s Hudson River Park 3Health News:Flood Law Group Comments on Recent AAICH Study 2Health News:In My Solitude Unveils Eco Candle Line That May Improve Performance 2Health News:Best-selling Author Janice Holly Booth Offers Tips to Navigating Fear and Living a Fuller Life 2
... of relative dormancy after a series of lawsuits prompted their removal ... Drug Administration approved them for use in breast augmentation and breast ... why he feels the FDA’s decision was correct. , ... ...
... Inc., provider of nurse training seminars on DVD and online is pleased ... ... 2009 -- Medical Nurse Training, Inc., provider of nurse training seminars on ... , ,Medical Nurse Training, Inc. provides DVD and online courses aimed at ...
... symptoms during pregnancy, such as morning sickness, fatigue and weight gain, but ... come. At Gurgle, we offer a guide to women in their early ... ... London, England (PRWEB) April 2, 2009 -- Around half of all women ...
... Some of the symptoms of the autistic condition Asperger Syndrome, ... could be linked to levels of the stress hormone cortisol, ... Normally, people have a surge of this hormone shortly after ... thought this surge makes the brain alert, preparing the body ...
... social care services face a host of new challenges ... personal budgets* in social care. The issues raised for ... are outlined in ,The impact of personal budgets on ... booklet highlights the views of leading experts on social ...
... in Pasadena and San DiegoST. JOSEPH, Mo., April 1 ... getting their pets, hearts checked is a walk in ... Tour will make stops in April 4 and 5 with ... parks to perform free heart examinations of area dogs.In addition ...
Cached Medicine News:Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 2Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 3Health News:New Hampshire Cosmetic Plastic Surgeon Discusses Silicone Breast Implants after Breast Augmentation becomes No. 1 Cosmetic Surgery Procedure 4Health News:Medical Nurse Training, Inc. Announces the Launch of Medicalnursetraining.com 2Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 2Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 3Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 4Health News:Gurgle's Guide on How to Beat Morning Sickness and Pregnancy Fatigue 5Health News:Autism linked with stress hormone levels 2Health News:Third sector gears up to meet 2Health News:Third sector gears up to meet 3Health News:Mobile Dog Heart Health Tour Through California Cities to Provide Free Heart Examinations in Sound-Proof Setting 2Health News:Mobile Dog Heart Health Tour Through California Cities to Provide Free Heart Examinations in Sound-Proof Setting 3
... The Px2 Thermal Cycler is Thermo ... machine to date with easy to use ... display for easy programming. Designed to offer ... the Px2 incorporates a number of customer ...
... Advanced Design With Exceptional Performance ... user interface might be the ... the MyCycler is designed for ... at a premium, its small ...
96 well thermocycler with unique High Temperature Range (HTR) Peltier technology for fastest available heating and cooling rates up to 4C/sec with High Pressure Lid for automated sealing of PCR plate...
... speeds, highest precision, more user-friendliness and absolute ... is the definition of the Mastercycler ep ... acid research has been developing dynamically. The ... PCR Systems. To keep pace with ...
Medicine Products: